Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2012 1
2014 1
2016 1
2017 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Trends in HIV prevalence, incidence, and progress towards the UNAIDS 95-95-95 targets in Malawi among individuals aged 15-64 years: population-based HIV impact assessments, 2015-16 and 2020-21.
Payne D, Wadonda-Kabondo N, Wang A, Smith-Sreen J, Kabaghe A, Bello G, Kayigamba F, Tenthani L, Maida A, Auld A, Voetsch AC, Jonnalagadda S, Brown K, West CA, Kim E, Ogollah F, Farahani M, Dobbs T, Jahn A, Mirkovic K, Nyirenda R; MPHIA Study Team. Payne D, et al. Lancet HIV. 2023 Sep;10(9):e597-e605. doi: 10.1016/S2352-3018(23)00144-3. Epub 2023 Aug 13. Lancet HIV. 2023. PMID: 37586390 Free PMC article.
Assessing the impact of the COVID-19 restrictions on HIV testing services in Malawi: an interrupted time series analysis.
Afirima B, Iyamu IO, Yesufu ZA, Iwara E, Chilongozi D, Banda L, Zenengeya E, Mablekisi C, Matatiyo B, Kuye J, Michael O, Gonani A, Ruberintwari M, Madidi N, Oladele E, Akolo C. Afirima B, et al. Among authors: matatiyo b. Afr J AIDS Res. 2023 Jul;22(2):92-101. doi: 10.2989/16085906.2023.2197883. Epub 2023 Jul 3. Afr J AIDS Res. 2023. PMID: 37395508
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.
Wadonda-Kabondo N, Bennett D, van Oosterhout JJ, Moyo K, Hosseinipour M, Devos J, Zhou Z, Aberle-Grasse J, Warne TR, Mtika C, Chilima B, Banda R, Pasulani O, Porter C, Phiri S, Jahn A, Kamwendo D, Jordan MR, Kabuluzi S, Chimbwandira F, Kagoli M, Matatiyo B, Demby A, Yang C. Wadonda-Kabondo N, et al. Among authors: matatiyo b. Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S362-8. doi: 10.1093/cid/cir987. Clin Infect Dis. 2012. PMID: 22544204 Free PMC article.
Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
Tagar E, Sundaram M, Condliffe K, Matatiyo B, Chimbwandira F, Chilima B, Mwanamanga R, Moyo C, Chitah BM, Nyemazi JP, Assefa Y, Pillay Y, Mayer S, Shear L, Dain M, Hurley R, Kumar R, McCarthy T, Batra P, Gwinnell D, Diamond S, Over M. Tagar E, et al. Among authors: matatiyo b. PLoS One. 2014 Nov 12;9(11):e108304. doi: 10.1371/journal.pone.0108304. eCollection 2014. PLoS One. 2014. PMID: 25389777 Free PMC article.